- FREE SHIPPING! on orders over $95*
Mekinist
Price range: $1,700.00 through $5,500.00
Mekinist (trametinib) is a targeted MEK inhibitor for treating BRAF-mutated melanoma, non-small cell lung cancer, anaplastic thyroid cancer, and other solid tumors. This once-daily oral medication blocks cancer cell growth pathways, often combined with dabrafenib for enhanced effectiveness. For patients researching online medicine order options, Mekinist requires BRAF mutation testing before starting, regular monitoring for heart/eye/skin side effects, and close coordination with oncology specialists to manage treatment effectively while accessing manufacturer assistance programs for this high-cost specialty medication.
- Prescription Required
- Please note all prices are in US dollars
Mekinist (trametinib) is a targeted cancer therapy that blocks MEK proteins, which are part of the signaling pathway that tells cancer cells to grow and divide. Unlike traditional chemotherapy that attacks all rapidly dividing cells, Mekinist specifically targets this MEK pathway, making it a precision medicine for certain types of cancer. It’s approved for melanoma (skin cancer) with specific BRAF mutations, either alone or combined with another targeted drug called dabrafenib. The medication comes in 0.5mg and 2mg tablets taken once daily on an empty stomach.
How Mekinist Works: Cancer cells with BRAF mutations have an overactive growth signal pathway. The BRAF protein sends signals through MEK proteins, which then tell the cancer cells to multiply uncontrollably. Mekinist blocks the MEK proteins in this chain reaction, essentially cutting off the “grow” signal to cancer cells. This causes cancer cells to stop dividing and often leads to tumor shrinkage.
Your doctor will test your tumor for BRAF V600E or V600K mutations before prescribing Mekinist, since the medication only works in cancers with these specific genetic changes. Not all melanomas have BRAF mutations, testing is required to determine if you’re a candidate for this treatment. When combined with dabrafenib (a BRAF inhibitor), the two drugs work together to block the cancer growth pathway at two different points, which can be more effective than either drug alone.
FDA-Approved Uses: Mekinist is approved for unresectable or metastatic melanoma with BRAF V600E or V600K mutations, as a single agent or with dabrafenib. It’s also approved (when combined with dabrafenib) for adjuvant treatment of melanoma after surgery in patients with lymph node involvement, metastatic non-small cell lung cancer with BRAF V600E mutations, locally advanced or metastatic anaplastic thyroid cancer with BRAF V600E mutations and no satisfactory treatment alternatives, and locally advanced or metastatic solid tumors with BRAF V600E mutations in pediatric patients 1 year and older who have progressed after prior treatment.
For patients managing multiple health conditions requiring medications from online pharmacy USA services, Mekinist requires careful coordination with your oncology team since drug interactions can affect treatment effectiveness or increase side effects.
Taking Mekinist Properly: Take your dose once daily at least 1 hour before or 2 hours after a meal. Food can affect how much medication your body absorbs, so consistent timing on an empty stomach ensures you get the right amount. Swallow tablets whole with water, don’t crush or chew them. If you miss a dose by less than 12 hours, take it as soon as you remember. If it’s been more than 12 hours, skip that dose and take your next scheduled dose.
Required Monitoring: Your healthcare team will monitor you closely throughout treatment. Expect regular blood tests to check liver function, blood cell counts, and electrolytes. You’ll need eye exams before starting treatment and periodically during therapy, since Mekinist can cause vision problems. Your doctor will also monitor your heart function with echocardiograms or MUGA scans, check your blood pressure regularly, and watch for skin changes since new skin cancers can develop during treatment.
Many patients experience side effects that require dose adjustments or temporary treatment breaks. Your oncologist may reduce your dose or pause treatment if certain side effects occur, this doesn’t mean the treatment isn’t working. Similar to patients using other targeted therapies like olaparib cost medications, managing side effects is part of the treatment process and helps you stay on therapy longer.
| Brand | Mekinist Brand |
|---|---|
| Form | 0.5mg 30 Tablets, 2mg 30 Tablets |
Side Effects:
Common side effects include rash and acne-like skin problems, diarrhea, swelling in legs/feet/hands, fatigue, high blood pressure, nausea, mouth sores, and changes in skin/hair/nail appearance. When combined with dabrafenib, fever is very common and can be severe. Most patients experience some side effects, but many are manageable with supportive medications or dose adjustments. Skin rash occurs in about 60% of patients and usually develops within the first few weeks of treatment.
Serious side effects requiring immediate medical attention include vision changes or eye pain (can indicate retinal problems), bleeding or easy bruising, signs of blood clots (leg pain/swelling, chest pain, shortness of breath), heart problems (irregular heartbeat, chest discomfort, shortness of breath), lung issues (new or worsening cough, trouble breathing), severe diarrhea or dehydration, severe rash or skin reactions, fever above 101.3°F (especially if combined with dabrafenib), or signs of liver problems (yellowing skin/eyes, dark urine, severe fatigue).
Long-term concerns include development of new skin cancers (squamous cell carcinoma, new melanomas), which is why regular skin checks are required. The medication can cause permanent eye damage affecting vision, heart muscle problems, and hemorrhage. For patients ordering other medications through order medication online services, inform your oncologist about all drugs you're taking, as interactions can worsen side effects or reduce Mekinist's effectiveness.
Indications and Approved Uses:
Mekinist is FDA-approved for unresectable or metastatic melanoma with BRAF V600E or V600K mutations (as single agent or with dabrafenib), adjuvant treatment of melanoma with BRAF V600E or V600K mutations and lymph node involvement following complete resection (with dabrafenib), metastatic non-small cell lung cancer with BRAF V600E mutation (with dabrafenib), locally advanced or metastatic anaplastic thyroid cancer with BRAF V600E mutation with no satisfactory locoregional treatment options (with dabrafenib), and unresectable or metastatic solid tumors with BRAF V600E mutation in pediatric patients 1 year and older who have progressed after prior treatment or have no satisfactory alternative therapy (with dabrafenib).
The standard dose is 2mg once daily for both monotherapy and combination therapy with dabrafenib. Pediatric dosing is weight-based. BRAF mutation testing is required before starting treatment. The medication works by blocking MEK proteins in the cancer growth pathway, causing tumor shrinkage in many patients. Response rates vary by cancer type and whether Mekinist is used alone or with dabrafenib—combination therapy generally produces better results. Treatment continues until disease progression or unacceptable toxicity. Regular monitoring includes blood tests, heart function checks, eye exams, and skin evaluations. For patients researching cancer medications options, working with oncology specialists ensures proper genetic testing, appropriate treatment selection, and comprehensive side effect management throughout therapy.
Frequently Asked Questions:
How long does Mekinist take to work?
Many patients see tumor shrinkage within 2-3 months of starting treatment. Your doctor will do CT scans or other imaging every 2-3 months to check how well the cancer is responding. Some people respond quickly within weeks, while others take longer. If scans show the cancer is growing after several months of treatment, your doctor may switch to a different therapy since Mekinist isn't working for your cancer.
Why can't I take Mekinist with food?
Food significantly increases how much trametinib your body absorbs, which could lead to higher drug levels and more side effects. Taking it on an empty stomach (1 hour before or 2 hours after eating) ensures consistent absorption and predictable blood levels. This helps your doctor determine the right dose and reduces the risk of toxicity from too-high levels.
Will I lose my hair on Mekinist?
Unlike chemotherapy, Mekinist doesn't typically cause complete hair loss. However, you may notice your hair becomes thinner, grows more slowly, or changes texture. Some patients report their hair becomes curlier or changes color. These changes are usually reversible after stopping treatment. You're more likely to experience skin and nail changes than significant hair loss.
Can I take other medications while on Mekinist?
Some medications can interact with Mekinist. Tell your oncologist about everything you take, including over-the-counter drugs, supplements, and medications ordered through best usa online pharmacy services. Drugs that affect certain liver enzymes can change Mekinist levels in your blood. Your doctor may need to adjust doses or choose alternative medications to avoid interactions.
What should I do if I develop a fever while taking Mekinist with dabrafenib?
Fever is common when Mekinist is combined with dabrafenib, occurring in about 70% of patients. If your temperature reaches 101.3°F or higher, contact your oncologist immediately. They may instruct you to stop both drugs temporarily and take fever reducers. Severe fevers can lead to serious complications, so don't wait to report them. Your doctor may prescribe preventive medications or adjust your doses to reduce fever episodes.
How much does Mekinist cost and are there assistance programs?
Mekinist is expensive, often costing over $10,000 monthly without insurance. However, the manufacturer offers copay assistance programs for eligible patients with commercial insurance. Patients with Medicare may qualify for foundation assistance. Uninsured patients may access the medication through patient assistance programs. Work with your oncology team's financial counselor or explore options through online medical store services specializing in oncology medications to find programs that can help cover costs.
The content on this page has been supplied to onlinepharmacynow.com by an independent third party contracted to provide information for our website. onlinepharmacynow.com relies on these third parties to create and maintain this information and cannot guarantee the accuracy or reliability of the information that has been provided to us.
The drug information provided here is only a summary and does not contain all the list of possible side effects and drug interactions regarding this medication. Be sure to contact your doctor or pharmacist if you have any specific question or concern. If you require any advice or information about the drugs on this page, a medical condition or treatment advice, you should always speak to a healthcare professional.
Please note that not all products, including any referenced in this page, are shipped by our affiliated Europe Pharmacy. We are affiliated with other dispensaries that ship product to our customers from the following jurisdictions: Canada, New Zealand, Turkey and United Kingdom. The items in your order maybe shipped from any of the above jurisdictions. The products are sourced from various countries as well as those listed above. Rest assured, we only affiliate with our authorized dispensaries that procure product through reliable sources.
Required
Send Your Prescription
Secure Payment
No Hidden Fees
Fast Shipping
Typically Under 7 days
Ask an expert
Reviews
There are no reviews yet.